Anticoagulants - GEN - Genetic Engineering and Biotechnology News

Illustration of human blood cells

Anticoagulants

Bleeding Edge: Anthos Pursues a Monthly Anticoagulant

Anticoagulants

AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals

UW Medicine Microbiology Lab

Anticoagulants

“Anti-Evolution Drugs” Could Offer New Strategy against Antimicrobial Resistance Crisis

Anticoagulants

Xarelto Fails Phase III Trial in ESUS

Anticoagulants

Thrombin-Responsive Patch Dispenses Blood-Thinning Drugs as Needed

Anticoagulants

Portola Inks Deals for Factor Xa Antidote with BMS, Pfizer, Bayer

Anticoagulants

Daiichi Sankyo to Develop Translational Sciences’ TS23

Anticoagulants

Drug Re-engineered to Improve Surgery Safety

Anticoagulants

Hepalink Agrees to Acquire Scientific Protein Laboratories

Anticoagulants

GSK Sells Thrombosis Brands to Aspen for $1.13B

Anticoagulants

BMS, Pfizer, Portola Study Antidote, Factor Xa Inhibitor

Anticoagulants

Failure of Anticoagulant Prompts BioInvent to Seek $2.2M Cost Cuts

Anticoagulants

Studies Provide Structural Insights on Activation, Conversion of Plasminogen to Plasmin

Anticoagulants

FDA Approves AstraZeneca’s Antiplatelet Drug

Anticoagulants

Japan Is First Country to Approve Daiichi Sankyo’s Direct Factor Xa...

12 Page 1 of 2